Skip to content
    Thuja Capital logo

    Thuja Capital

    Utrecht, NetherlandsFounded 2006
    www.thujacapital.comLinkedIn
    Biotech & Life SciencesHealthcare

    Thuja Capital is an independent early-stage venture capital firm based in the Netherlands, specializing in investments in innovative life science and medical product companies across the Benelux region. The firm is currently investing out of its Thuja Capital Healthcare Fund III, which closed in December 2021 at EUR 76M (~USD 86M).

    52% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (41% of deals). Average disclosed round size is $17.8M (across 5 rounds with reported amounts).

    Find people at Thuja Capital on Goldilocks AI

    Portfolio

    20

    Fund Size

    $86M

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    HV

    Harrold van Barlingen

    Managing Partner

    MB

    Michel Briejer

    Managing Partner

    EC

    Evan Castiglia

    Partner

    FL

    Florian Ludwig

    Venture Partner

    LB

    Lisanne Blauw

    Associate

    MD

    Michel de Baar

    Biotech Investor

    EP

    Eleanor Price

    Healthcare VC

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    27 investments
    CompanyRoundAmountDate
    Salvia BioElectronics logoSalvia BioElectronicsSeries B$60MMay 2025
    Alesta logoAlestaSeries A—Jan 2025
    Alesta Therapeutics logoAlesta TherapeuticsSeries A—Jan 2025
    Artica Therapeutics logoArtica TherapeuticsPre-Seed—Jan 2023
    Synerkine Pharma logoSynerkine PharmaSeries A—Jan 2023
    InnoSIGN logoInnoSIGNSeries A$8MJan 2022
    EsoBiotec logoEsoBiotecUnknown$250KJan 2021
    Synerkine Pharma logoSynerkine PharmaSeries A—Jan 2021
    Salvia BioElectronics B.V. logoSalvia BioElectronics B.V.Unknown—Sep 2020
    Salvia BioElectronics logoSalvia BioElectronicsSeries A—Sep 2020
    IIndigo DiabetesSeries B—Jul 2020
    Salvia BioElectronics logoSalvia BioElectronicsSeries A—Jan 2020
    Tacalyx logoTacalyxSeed—Sep 2019
    AAlveron PharmaSeed—Jan 2019
    Synerkine Pharma logoSynerkine PharmaSeries A—Jan 2019
    Mellon Medical logoMellon MedicalUnknown—Oct 2017
    Mellon Medical logoMellon MedicalUnknown—Jan 2017
    NNightbalanceSeries B$12.5MJul 2016
    OOkapi SciencesUnknown—Nov 2008
    Fundamental Pharma logoFundamental PharmaSeed——
    Gradient Denervation Technologies logoGradient Denervation TechnologiesSeries A——
    IIndigo DiabetesSeries A——
    Atro logoAtroUnknown——
    PPan Cancer TUnknown——
    IInnoSIGNSeries A$8M—
    Page 1 of 2

    Top Co-Investors

    INKEF Capital5 shared
    BioGeneration Ventures5 shared
    InnovationQuarter4 shared
    Dolby Family Ventures3 shared
    Brabantse Ontwikkelings Maatschappij (BOM)3 shared
    European Innovation Council (EIC)3 shared
    Sofinnova Partners2 shared
    coparion2 shared
    High-Tech Gründerfonds2 shared
    Novartis Venture Fund2 shared
    Frazier Life Sciences2 shared
    Casdin Capital2 shared
    Life Science Angels2 shared
    PMV2 shared
    Fund+2 shared
    SHS Capital1 shared
    Invest-NL1 shared
    OSS Capital1 shared
    Innovation Industries1 shared
    Boehringer Ingelheim Venture Fund1 shared

    Last updated: 20 October 2026